DFCM
ALXO icon

Dark Forest Capital Management’s ALX Oncology ALXO Stock Holding History

Dark Forest Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,331
Closed -$11K – 1110
2022
Q2 		$11K Buy
1,331
+519
+64% +$5.65K ﹤0.01% 512
2022
Q1 		$13K Sell
812
-17,940
-96% -$306K ﹤0.01% 938
2021
Q4 		$403K Buy
+18,752
New +$809K 0.15% 149

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Dark Forest Capital Management's ALXO Position: Q3 2022 in Review

Dark Forest Capital Management sold out of ALX Oncology (ALXO) in Q3 2022, closing a stake of 1,331 shares — an estimated $11K sold.

Dark Forest Capital Management first reported a position in ALXO in Q4 2021 and held it in 3 quarters. The position peaked at $403K in Q4 2021. 99 funds tracked by Wall St. Rank hold ALXO as of Q3 2022.

  • Dark Forest Capital Management reported no remaining ALX Oncology position as of Q3 2022 after selling out during the quarter.
  • Dark Forest Capital Management sold 1,331 ALX Oncology shares in Q3 2022, an estimated $11K.
  • Dark Forest Capital Management first reported a position in ALX Oncology in Q4 2021 and held it in 3 quarters.
  • Dark Forest Capital Management's ALX Oncology position peaked at $403K in Q4 2021.
  • 99 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2022.

Based on Dark Forest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.